Unraveling the mechanisms of intrinsic drug resistance in Mycobacterium tuberculosis

Unraveling the mechanisms of intrinsic drug resistance in Mycobacterium tuberculosis

Tuberculosis (TB) is among the most difficult infections to treat, requiring several months of multidrug therapy to produce a durable cure. The reasons necessitating long treatment times are complex and multifactorial. However, one major difficulty of treating TB is the resistance of the infecting b...

Full description

Bibliographic Details
Main Authors:	Nicholas C. Poulton, Jeremy M. Rock
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	tuberculosis intrinsic resistance chemical genetics drug repurposing drug discovery
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.997283/full

Similar Items

Editorial: Drug-resistant Mycobacterium tuberculosis
by: Helena I. M. Boshoff, et al.
Published: (2023-05-01)

Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach
by: Lalu Muhammad Irham, et al.
Published: (2022-12-01)

Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs
by: José Manuel Ezquerra-Aznárez, et al.
Published: (2021-11-01)

Editorial: Approaches to Address Resistance, Drug Discovery, and Vaccine Development in Mycobacterium tuberculosis: Challenges and Opportunities
by: Sandeep Sharma, et al.
Published: (2022-04-01)

Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex
by: Matthias Merker, et al.
Published: (2020-03-01)

Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis
by: Divakar Sharma, et al.
Published: (2017-12-01)

How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery
by: Amala Bhagwat, et al.
Published: (2022-09-01)

The Patterns of Conversion to Anti-Tuberculosis Drug Resistance in Mycobacterium tuberculosis
by: Moo-Sang Chong, et al.
Published: (2022-06-01)

Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment
by: Filia Stephanie, et al.
Published: (2021-04-01)

Editorial: Novel Strategies in Drug Development Against Multifactorial Diseases
by: Cinzia Esposito, et al.
Published: (2022-01-01)

Drug-resistant Mycobacterium tuberculosis, Taiwan
by: Ruwen Jou, et al.
Published: (2006-05-01)

The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review
by: Chiyun Lee, et al.
Published: (2021-01-01)

Phenotypic and genomic comparison of Mycobacterium aurum and surrogate model species to Mycobacterium tuberculosis: implications for drug discovery
by: Amine Namouchi, et al.
Published: (2017-07-01)

Drug Resistance Conferring Mutation and Genetic Diversity of Mycobacterium tuberculosis Isolates in Tuberculosis Lymphadenitis Patients; Ethiopia
by: Ayalew S, et al.
Published: (2021-02-01)

Multi-Drug Resistance of Mycobacterium Tuberculosis – the Problem of Modern Phthisiology
by: E. Yu. Zorkaltseva, et al.
Published: (2019-05-01)

Drug Resistance Mechanisms in Mycobacterium tuberculosis
by: Juan Carlos Palomino, et al.
Published: (2014-07-01)

Mycobacterium tuberculosis Drug Resistance, Ghana
by: Ellis Owusu-Dabo, et al.
Published: (2006-07-01)

The spectrum of primary drug resistance of Mycobacterium tuberculosis in patients with tuberculosis in relation to human immunodeficiency virus status
by: V N Zimina, et al.
Published: (2017-11-01)

In vivo evolution of drug-resistant Mycobacterium tuberculosis in patients during long-term treatment
by: Yuhui Xu, et al.
Published: (2018-08-01)

Novel Treatments against <i>Mycobacterium tuberculosis</i> Based on Drug Repurposing
by: Álvaro Mourenza, et al.
Published: (2020-08-01)

Mycobacterium tuberculosis Drug Resistance, Abkhazia
by: Manuela Pardini, et al.
Published: (2005-03-01)

Mycobacterium tuberculosis Molecular Determinants of Infection, Survival Strategies, and Vulnerable Targets
by: Davide M. Ferraris, et al.
Published: (2018-02-01)

Pyrazinamide Susceptibility Is Driven by Activation of the SigE-Dependent Cell Envelope Stress Response in Mycobacterium tuberculosis
by: Joshua M. Thiede, et al.
Published: (2022-02-01)

Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains in geriatrics: An analysis and its implications in tuberculosis control
by: Ajoy Kumar Verma, et al.
Published: (2022-05-01)

MtrA modulates Mycobacterium tuberculosis cell division in host microenvironments to mediate intrinsic resistance and drug tolerance
by: Eliza J.R. Peterson, et al.
Published: (2023-08-01)

Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy
by: Andrés Pizzorno, et al.
Published: (2019-03-01)

An overview of current strategies and future prospects in drug repurposing in tuberculosis
by: Dilpreet Singh, et al.
Published: (2023-02-01)

DNA Fingerprinting of Resistant Mycobacterium tuberculosis Isolates in Iran by IS6110-RFLP Method
by: Aliasghar Farazi, et al.
Published: (2019-08-01)

Biophysical and Integrative Characterization of Protein Intrinsic Disorder as a Prime Target for Drug Discovery
by: Shuqi Luo, et al.
Published: (2023-03-01)

Editorial: New Approaches Against Drug-Resistant M. tuberculosis
by: Yossef Av-Gay, et al.
Published: (2021-04-01)

Genetic diversity of drug-resistant Mycobacterium tuberculosis clinical isolates from Khuzestan province, Iran
by: Pejman Bakhtiyariniya, et al.
Published: (2022-07-01)

Drug Resistance in Mycobacterium Tuberculosis Isolates to Isoniazid and Rifampin
by: M Pourhajibagher, et al.
Published: (2012-05-01)

Phenotypic Drug Resistance and Gene Mutation in Mycobacterium Tuberculosis with and without Diabetes: a Prospective Study
by: Yingmei ZHANG, Fei WANG, Xiaobing REN, Yuelian WANG, Jun CHEN, Ying HU, Xiaoqin HU, Wenge XU
Published: (2022-10-01)

Inhibition of Glutamine Synthetase: A Potential Drug Target in Mycobacterium tuberculosis
by: Sherry L. Mowbray, et al.
Published: (2014-08-01)

State-of-the-art strategies to prioritize Mycobacterium tuberculosis drug targets for drug discovery using a subtractive genomics approach
by: Adetutu Akinnuwesi, et al.
Published: (2023-09-01)

Genotyping and drug resistance patterns of Mycobacterium tuberculosis strains observed in a tuberculosis high-burden municipality in Northeast, Brazil
by: Roberta dos Santos Silva Luiz, et al.

Genotyping and drug resistance patterns of Mycobacterium tuberculosis strains observed in a tuberculosis high-burden municipality in Northeast, Brazil
by: Roberta dos Santos Silva Luiz, et al.
Published: (2013-06-01)

Repurposing antifungal drugs for cancer therapy
by: Ningna Weng, et al.
Published: (2023-06-01)

Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis
by: Shasank S. Swain, et al.
Published: (2020-01-01)

Structure-based in silico approaches for drug discovery against Mycobacterium tuberculosis
by: Alexander D.H. Kingdon, et al.
Published: (2021-01-01)